SAB Biotherapeutics (SABS) P/E (2021 - 2026)
SAB Biotherapeutics (SABS) P/E from Dec 31, 2021 to Jun 12, 2026. The TTM SAB Biotherapeutics (SABS) P/E is 13.00. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of SAB Biotherapeutics (SABS)
| Year | P/E | Change |
|---|---|---|
| 2026 | 13.00 | +29.91% |
| 2025 | 10.00 | -240.01% |
| 2024 | -7.15 | -44.81% |
| 2023 | -12.95 | +13.73% |
| 2022 | -11.38 | -96.13% |
| 2021 | -294.06 | N/A |
Comparison SAB Biotherapeutics (SABS) P/E with competitors
SAB Biotherapeutics (SABS) P/E is 13.00.